Curcuma longa decreased knee pain but did not affect knee effusion-synovitis or cartilage composition in knee osteoarthritis.
When a safe and effective vaccine against COVID-19 becomes available, it is likely to take 6 to 9 months to have a significant impact.
This study compared the efficacy of trigger point injections with conventional therapy for myofascial back and neck pain in the acute care setting.
The AAAHC developed the toolkit as an informational resource for managing pain in both primary care and surgical practices.
There was widespread reporting of avoidance of medical care due to COVID-19-related concerns in June 2020.
A considerable proportion of children with confirmed COVID-19 remain asymptomatic.
Researchers evaluated the long-term effect of mobilization with movement on disability, pain, and function in patients with symptomatic knee osteoarthritis.
Barhemsys, a selective dopamine-2 and dopamine-3 receptor antagonist, is indicated for the prevention of postoperative nausea and vomiting.
Orphengesic Forte for the symptomatic relief of mild to moderate pain of acute musculoskeletal disorders now available.
Influenza vaccination should occur by the end of October, if possible.